HIND - Vyome Holdings Inc.
2.8
-0.110 -3.929%
Share volume: 31,345
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.91
-0.11
-0.04%
Fundamental analysis
38%
Profitability
35%
Dept financing
41%
Liquidity
38%
Performance
41%
Performance
5 Days
-17.89%
1 Month
8.95%
3 Months
-51.13%
6 Months
-65.39%
1 Year
209.39%
2 Year
1,553.87%
Key data
Stock price
$2.80
DAY RANGE
$2.74 - $2.99
52 WEEK RANGE
$0.30 - $16.00
52 WEEK CHANGE
$281.16
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
Company detail
CEO: Paul F. Hickey
Region: US
Website: reshapelifesciences.com
Employees: 50
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: reshapelifesciences.com
Employees: 50
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. Its product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes.
Recent news